LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

Home・Listă Acțiuni・Celldex Therapeutics Inc

Celldex Therapeutics Inc

Închisă

SectorSănătate

22.87 -1.63

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

22.7

Maxim

22.99

Indicatori cheie
By Trading Economics
Venit	-2.8M -57M
Vânzări	35K 730K
Marjă de profit	-7,753.425
Angajați	186
EBITDA	-1.1M -63M

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+111.52% upside

Dividende
By Dow Jones
Următoarele câștiguri	11 nov. 2025

Statistici piață
By TradingEconomics
Capitalizare de piață	196M 1.6B
Deschiderea anterioară	24.5
Închiderea anterioară	22.87

Sentimentul știrilor

By Acuity

100%

363 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Weak Bullish Evidence

18.91 / 20.63 Suport & Rezistență

Celldex Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

7 nov. 2025, 21:06 UTC

Principalele dinamici ale pieței

JBS Down After Trump Calls for Probe into Meat-Packing Companies

7 nov. 2025, 22:36 UTC

Câștiguri

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

7 nov. 2025, 22:22 UTC

Câștiguri

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

7 nov. 2025, 22:03 UTC

Câștiguri

Constellation Software 3Q Rev $2.95B >CSU.T

7 nov. 2025, 22:03 UTC

Câștiguri

Constellation Software 3Q Net $210M >CSU.T

7 nov. 2025, 22:03 UTC

Câștiguri

Constellation Software 3Q EPS $9.89 >CSU.T

7 nov. 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

7 nov. 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

7 nov. 2025, 20:59 UTC

Câștiguri

Palantir's CEO Says His Earnings Were the Best Ever. They Weren't Even the Best of the Week. -- Barrons.com

7 nov. 2025, 20:26 UTC

Market Talk

Natural U.S. Gas Futures Extend Rally to Three Weeks -- Market Talk

7 nov. 2025, 20:22 UTC

Câștiguri

Free-Spending Big Tech Dominates Earnings. As for the Rest: Don't Miss. -- Barrons.com

7 nov. 2025, 20:04 UTC

Market Talk

Oil Futures Close Choppy Week With Losses -- Market Talk

7 nov. 2025, 19:34 UTC

Market Talk

Gold Posts Small Gain for Week -- Market Talk

7 nov. 2025, 19:31 UTC

Market Talk

Achiziții, Fuziuni, Preluări

Prices of Gas-Fired Power Plants Have Room to Grow -- Market Talk

7 nov. 2025, 19:17 UTC

Câștiguri

These Stocks Are Moving the Most Today: Tesla, Expedia, Take-Two, Block, Affirm, Sunrun, Globus Medical, JFrog, and More -- Barrons.com

7 nov. 2025, 19:09 UTC

Câștiguri

Wendy's Turnaround Won't Be Easy. Earnings, and the Stock, Tell the Story. -- Barrons.com

7 nov. 2025, 19:08 UTC

Câștiguri

KKR Defied Private-Equity Fundraising Slump in the Third Quarter -- WSJ

7 nov. 2025, 18:31 UTC

Market Talk

U.S. Oil RIg Count Unchanged at 414 -- Market Talk

7 nov. 2025, 17:27 UTC

Market Talk

EPA Announces New Exemptions to Biofuel Blending Rules -- Market Talk

7 nov. 2025, 17:20 UTC

Market Talk

Eli Lilly GLP-1 Deal with Trump Administration Provides Net Boost -- Market Talk

7 nov. 2025, 17:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

7 nov. 2025, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7 nov. 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

7 nov. 2025, 17:17 UTC

Achiziții, Fuziuni, Preluări

Satair Expects to Complete Purchase in Early 2026

7 nov. 2025, 17:17 UTC

Achiziții, Fuziuni, Preluări

Satair: Deal Includes Unical's and ecube's Seven Operational Sites and Offices, With Combined 2024 Rev of $298M and Headcount of 413

7 nov. 2025, 17:15 UTC

Achiziții, Fuziuni, Preluări

Airbus Unit Satair to Buy Unical Aviation From Platinum Equity

7 nov. 2025, 17:09 UTC

Market Talk

PENN Is Falling Further Behind Competitors -- Market Talk

7 nov. 2025, 16:49 UTC

Market Talk

Losing ESPN Partnership Will Hurt PENN -- Market Talk

7 nov. 2025, 16:24 UTC

Market Talk

OPEC+'s Output Hike Pause Comes Amid Excess Supply, Lower Spare Capacity -- Market Talk

7 nov. 2025, 16:17 UTC

Market Talk

Oil Market Faces Oversupply But "Glut" Might Be Overblown -- Market Talk

Comparație

Modificare preț

Celldex Therapeutics Inc Așteptări

Obiectiv de preț

By TipRanks

111.52% sus

Prognoză pe 12 luni

Medie 49.2 USD 111.52%

Maxim 67 USD

Minim 25 USD

În baza a 12 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruCelldex Therapeutics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

12 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 12 analiști care au acordat evaluări ale acțiunilor Celldex Therapeutics Inc - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

18.91 / 20.63Suport & Rezistență

Recent bullish events outweigh bearish events.

All events are bearish.

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.